CompletedNot Applicable

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

South Korea1 participantsStarted 2017-01-01

Plain-language summary

The purpose of this study was to investigate the clinical outcomes of patients with locally advanced pancreatic cancer (LA-PC) who underwent surgery after neoadjuvant chemotherapy (NACT) at Asan Medical Center's Department of Hepato-Biliary-Pancreatic Surgery from 2017 to 2020.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The study population consists of patients who underwent pancreatectomy for pancreatic adenocarcinoma between January 2017 and December 2020 Exclusion Criteria: * None

What they're measuring

oncologic outcome

Timeframe: 3 - 5 years after surgery

Trial details

NCT IDNCT05888129

SponsorAsan Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Postoperative Complications trials